# Epicore Biosystems funding: rounds and investors

> Epicore Biosystems has raised $6.0M across 1 round since 2025. Investors include Alumni Ventures, National Institutes of Health and Chevron Technology Ventures.

Source: https://millionrounds.com/company/epicore-biosystems (Millionrounds; every figure on the page links to its filing or article)

United States · [Series B startup](https://millionrounds.com/companies)

# Who invested in *Epicore Biosystems*

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summary Updated 26 Oct 2026

**$6.0M** raised across 1 round since 2025, from 1 source

- **Latest round:** Series B, $6.0M May 2025
- **Investors:** 4

See who backed them

## The rounds

- **May 2025** Series B **$6.0M** [Alumni Ventures](https://millionrounds.com/fund/us-strategic-tech-fund-an-alumni-ventures-fund) [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) [Chevron Technology Ventures](https://millionrounds.com/fund/chevron-technology-ventures) [Pegasus Tech Ventures](https://millionrounds.com/fund/pegasus-tech-ventures) Source recorded SEC filing: $26M sold, first sale Dec 2024

## Founders and team

From Epicore Biosystems's own website: 1 founder, 22 on the team.

**Stephen Lee** Chief Technology Officer/Co-Founder

- **Brian Reagan** Chief Commercial Officer
- **John Wright** Chief Operations Officer
- **Matt Marrapode** Chief Strategy Officer
- **Weihua Li** Chief Software Officer
- **Brandon Suleski** VP, Product Development
- **David MacIntosh** VP, Cloud Engineering
- **Giuseppe Stefanelli** Head of Finance
- **Gabriel Fagans** Manager, Product Development
- **Hakan B. Mutlu** Senior Director of Product Development
- **Jessica Wallace** Director, Product Development
- **Julia Spinelli** Director, Data Science
- **Karen Shieh** Senior Software Development Engineer
- **Katya Pniushkova** Biomedical and Field Applications Engineer
- **Kay McCall** Board Member
- **Kimberly Querrey** Board Member
- **Maura Buckley** Director, Product Development and Engagement
- **Meg Clark** Account Manager
- **Mike Edelhart** Board Member, Chair

And 4 more on the team.

Advisers *Laura Lang* *Stephen Schweich*

## Everyone who backed them

[Alumni Ventures](https://millionrounds.com/fund/us-strategic-tech-fund-an-alumni-ventures-fund) VC firm **1** round

[National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) Government **1** round

[Chevron Technology Ventures](https://millionrounds.com/fund/chevron-technology-ventures) Corporate VC **1** round

[Pegasus Tech Ventures](https://millionrounds.com/fund/pegasus-tech-ventures) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=epicore-biosystems).

## Also claim to have backed them

This firm lists Epicore Biosystems as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[Joyance Partners](https://millionrounds.com/fund/joyance-partners) VC firm Per its own site

## Quick answers about Epicore Biosystems

### Who invested in Epicore Biosystems?

Epicore Biosystems's investors include Alumni Ventures, National Institutes of Health, Chevron Technology Ventures and Pegasus Tech Ventures.

### How much has Epicore Biosystems raised?

Epicore Biosystems has raised $6.0M across 1 round since 2025.

### When did Epicore Biosystems last raise?

Epicore Biosystems's most recent round was a Series B of $6.0M in May 2025.

### What was Epicore Biosystems's biggest round?

Its most recent round, $6.0M in May 2025, is also its largest on record.

### Who backed Epicore Biosystems first?

Epicore Biosystems's first round on record, in May 2025, was backed by Alumni Ventures, National Institutes of Health and Chevron Technology Ventures and 1 others.

### What stage is Epicore Biosystems at?

Epicore Biosystems's latest named round is a Series B, in May 2025.

### Where is Epicore Biosystems based?

Epicore Biosystems is based in the United States.

## Companies like Epicore Biosystems

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app